Table 1.

Patients’ Demographic Information With Regard to Treatment Groups A and B.

Parameter	Treatment Group		P
	Group A	Group B
Gender			.711
Female, n (%)	24 (40%)	26 (43.3%)
Male, n (%)	36 (60%)	34 (56.7%)
Age, mean ± SD (minimum, maximum)	4.55 ± 1.83 (2-10)	4.14 ± 2.48 (2-12)	.298
Living place			.648
Shiraz	58 (96.7%)	57 (95%)
Other	2 (3.3%)	3 (5%)
Symptom duration (days), mean ± SD (minimum, maximum)	3.08 ± 1.55 (1-7)	2.76 ± 1.59 (1-7)	.274